Acute-phase proteins and other systemic responses to inflammation.
暂无分享,去创建一个
[1] W. Dijk,et al. Interleukin‐6‐Type Cytokine‐induced Changes in Acute Phase Protein Glycosylationa a , 1995, Annals of the New York Academy of Sciences.
[2] P. Limburg,et al. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. , 1990, The Journal of rheumatology.
[3] T. Yue,et al. Interferon-inducible Protein-10 Involves Vascular Smooth Muscle Cell Migration, Proliferation, and Inflammatory Response* , 1996, The Journal of Biological Chemistry.
[4] L. Moldawer,et al. Proinflammatory cytokines, nutritional support, and the cachexia syndrome , 1997, Cancer.
[5] M. Brand,et al. Proinflammatory cytokines interleukin 1β and tumor necrosis factor α inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells , 1996 .
[6] Guy Hoffman,et al. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. , 1993, The Journal of clinical investigation.
[7] F. D. de Beer,et al. Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice , 1996, European journal of clinical investigation.
[8] L. Mccawley,et al. Alpha-1-antichymotrypsin inhibits the NADPH oxidase-enzyme complex in phorbol ester-stimulated neutrophil membranes. , 1992, Journal of immunology.
[9] A. Shaw,et al. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. , 1995, Immunity.
[10] L. Leon,et al. The adaptive value of fever. , 1996, Infectious disease clinics of North America.
[11] P. Edwards,et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. , 1995, Circulation.
[12] M. Jordana,et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.
[13] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[14] J. Roth,et al. Fever suppression by subdiaphragmatic vagotomy in guinea pigs depends on the route of pyrogen administration. , 1997, The American journal of physiology.
[15] M. Hentze,et al. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. , 1997, Journal of immunology.
[16] Thomas Francis,et al. SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.
[17] R. Dwek,et al. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. , 1990, Gut.
[18] J. Gauldie,et al. Murine cardiotrophin-1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[19] G. Lozanski,et al. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. , 1992, Cytokine.
[20] I. Kushner,et al. Kinetic modeling and mathematical analysis indicate that acute phase gene expression in Hep 3B cells is regulated by both transcriptional and posttranscriptional mechanisms. , 1995, The Journal of clinical investigation.
[21] L. Curtiss,et al. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. , 1995, Journal of lipid research.
[22] H. Kawaguchi,et al. Printed in U.S.A. Copyright © 1997 by The Endocrine Society Transcriptional Induction of Cyclooxygenase-2 in Osteoblasts Is Involved in Interleukin-6-Induced , 2022 .
[23] G. Vercellotti,et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor , 1993 .
[24] T. Spector,et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. , 1997, Arthritis and rheumatism.
[25] K. Feingold,et al. Effects of endotoxin and cytokines on lipid metabolism. , 1994, Current opinion in lipidology.
[26] P. Heinrich,et al. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. , 1992, Journal of immunology.
[27] L. Kanz,et al. In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates [see comments] , 1992 .
[28] T. Speroff,et al. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. , 1991, Journal of immunology.
[29] D. Xia,et al. Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. , 1996, American journal of respiratory and critical care medicine.
[30] C. Dinarello. Interleukin-1 and the pathogenesis of the acute-phase response. , 1984, The New England journal of medicine.
[31] R. Bone,et al. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. , 1996, Critical care medicine.
[32] R. Means. Pathogenesis of the anemia of chronic disease: A cytokine‐mediated anemia , 1995, Stem cells.
[33] T. Vischer,et al. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. , 1997, The Journal of rheumatology.
[34] H. Munro,et al. Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1. , 1990, The Journal of biological chemistry.
[35] M. V. van Leeuwen,et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. , 1994, The Journal of rheumatology.
[36] G. Lozanski,et al. Identification of a C-reactive Protein Binding Site in Two Hepatic Carboxylesterases Capable of Retaining C-reactive Protein within the Endoplasmic Reticulum* , 1996, The Journal of Biological Chemistry.
[37] I. Kushner. Regulation of the Acute Phase Response by Cytokines , 2015, Perspectives in biology and medicine.
[38] H. Meltzer,et al. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs , 1997, Psychiatry Research.
[39] D. Xia,et al. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[40] H. Colten,et al. Molecular Biology of the Acute Phase Plasma Proteins , 1987 .
[41] G. Chrousos,et al. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.
[42] J. Filep,et al. Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. , 1997, The Journal of clinical investigation.
[43] J. Banchereau,et al. Interleukin 4 inhibits the production of some acute‐phase proteins by human hepatocytes in primary culture , 1993, FEBS letters.
[44] I. Kushner,et al. SERUM C‐REACTIVE PROTEIN LEVELS IN DISEASE * , 1982, Annals of the New York Academy of Sciences.
[45] H. Moutsopoulos,et al. High C-reactive protein response in lupus polyarthritis. , 1983, Clinical and experimental rheumatology.
[46] J. Gauldie,et al. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. , 1987, Journal of immunology.
[47] P. Sehgal,et al. High levels of "complexed" interleukin-6 in human blood. , 1992, The Journal of biological chemistry.
[48] Dennis J. Rivet,et al. Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia , 1997, The Journal of experimental medicine.
[49] C. Gabay,et al. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. , 1997, The Journal of clinical investigation.
[50] S. Thompson,et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.
[51] W. van Dijk,et al. Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera , 1993, The Journal of experimental medicine.
[52] G. Fantuzzi,et al. Defective inflammatory response in interleukin 6-deficient mice , 1994, The Journal of experimental medicine.
[53] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[54] H. Baumann,et al. Insulin cooperates with IL-1 in regulating expression of alpha 1-acid glycoprotein gene in rat hepatoma cells. , 1994, Cytokine.
[55] T. Vischer,et al. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. , 1994, Arthritis and rheumatism.
[56] M. Feldmann,et al. Role of cytokines in rheumatoid arthritis. , 1996, Annual review of immunology.
[57] C. Dinarello. Cytokines as endogenous pyrogens. , 1999, The Journal of infectious diseases.
[58] I. Kushner. Semantics, inflammation, cytokines and common sense. , 1998, Cytokine & growth factor reviews.
[59] G. Ciliberto,et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. , 1997, The Journal of clinical investigation.
[60] P. Lansdorp,et al. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[61] S. Dower,et al. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. , 1994, Journal of immunology.